Resources

CDMO Brochure

BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO Logo Kit

A Tribute to Our Chairman

BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO Brand Logo Reveal

API Product List

Case Study: Development and production of NCE amid pandemic lockdowns and supply chain interruptions

Peptide Brochure

Our Vision and Values

Case Study: Asymmetric Catalysis: Rhodium-Catalyzed Hydrogenation for Tetrasubstituted Alkenes

Case Study: Achieving Sustainable, Higher-Yield, Cost-Effective API Through Phase-Appropriate Scale Up and Optimization

BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO’s State-of-the-Art Peptide Facility

Case Study - Scaling-up API chemistry for Phase 3 clinical trials

Case Study: Innovative Process Solutions and Cost-Efficient Scale Up to Produce a High-Purity Pharmaceutical Intermediate for Phase 3 Clinical Trials

Case Study: Innovative Synthesis of a 25AA Peptide – Tackling Insolubility and Impurities with SPPS

Thought Leadership at EPSC: Nicola Guibelina on Tackling SPPS Challenges